FDA Adverse Event Injury Summary report: N

PULSE GEN MODEL 1000

MDR report key: 18676036 · Received February 9, 2024

Report

Report Number
1644487-2024-00124
Event Type
Injury
Date Received
February 9, 2024
Date of Event
January 16, 2024
Report Date
April 1, 2024
Manufacturer
LIVANOVA USA, INC.
Product Code
LYJ
UDI-DI
05425025750405
PMA / PMN Number
P970003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

LIVANOVA USA, INC. SUBMITS THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION, BASED ON INFORMATION THAT LIVANOVA HAS OBTAINED, BUT MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION, OR A CONCLUSION BY FDA OR ANYONE ELSE, THAT THE DEVICE, LIVANOVA, OR LIVANOVA'S EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS¿ OR "MALFUNCTIONS¿. THESE WORDS ARE INCORPORATED INTO THE FDA 3500A MEDWATCH FORM BY THE FDA, AND LIVANOVA OBJECTS TO THEIR USE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT A SLEEP STUDY AND PER THE SLEEP SPECIALIST THE PATIENT WAS EXPERIENCING APNEA TRIGGERED BY VNS STIMULATION. THE NEUROLOGIST NOTED THAT THE WITH THEIR CURRENT DAY/NIGHT PROGRAMMING, IT DID SUGGEST THAT THE VNS CORRELATED TO THE APNEA. THE NEUROLOGIST'S PLAN WAS TO ADJUST THE PATIENT'S DAY/NIGHT SETTINGS AND WOULD MONITOR THE PATIENT MOVING FORWARD. THE PATIENT WAS SEEN IN CLINIC AND THE NIGHTTIME SETTINGS FOR THE NORMAL OUTPUT CURRENT WAS LOWERED TO 1MA. NO OTHER RELEVANT INFORMATION HAS BEEN RECEIVED TO DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
51044 PULSE GEN MODEL 1000 GENERATOR LYJ LIVANOVA USA, INC. 1000 815 05425025750405

Patients

Seq Age Sex Outcome Treatment
1 40 YR Female Other